<DOC>
	<DOCNO>NCT00498381</DOCNO>
	<brief_summary>Aim study : 1 . To compare level IL-6 mRNA expression peripheral blood monocyte normal subject patient OSAS 2 . To compare activation NF-B peripheral blood monocyte control subject patient OSAS ; Check correlation level L-6 mRNA expression activation NF-kB 3 . To determine effect CPAP activation NF-kB IL-6 peripheral blood monocyte patient moderate –severe OSAS</brief_summary>
	<brief_title>The Induction IL-6 NF-kB PBMC OSA</brief_title>
	<detailed_description>Obstructive sleep apnea syndrome ( OSAS ) emerge recent year important risk factor cardiovascular morbidity . The mechanism responsible development cardiovascular sequela patient OSA include hypoxia , hypercapnia , exaggerate negative intrathoracic pressure burst sympathetic activity provoke surge blood pressure heart rate . Meanwhile , increase inflammatory mediator , include C-reactive protein ( CRP ) , oxidative stress , adhesion molecule , vascular endothelial growth factor ( VEGF ) proinflammatory cytokine ( interleukin ( IL ) -1 , IL-2 , IL-6 , IL-8 , IL-10 tumor necrotic factor- ( TNF- ) ) , also involve development cardiovascular disease patient OSAS . According preliminary study , serum level IL-6 CRP high patient OSAS control subject level IL-6 CRP highly correlate low pulse oxygen saturation . Hypoxia trigger production IL-6 induction NFB , demonstrate ischemic heart disease pancreatitis . However , mechanism prooved OSAS . Therefore , conduct study prove hypothesis ( 1 ) The mRNA expression IL-6 peripheral blood monocyte significantly high patient OSAS control subject ( 2 ) The activation NF-k B peripheral blood monocyte significant patient OSAS control subject , level NF- kB activation associate level IL-6 mRNA expression ( 3 ) CPAP therapy could lower activation NF-kB IL-6 mRNA expression patient moderate-severe OSAS .</detailed_description>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>severe obstructive sleep apnea ( AHI &gt; =30 /hr ) male older 18 y/o refuse participate , chronic lung disease active infection neurologic event</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2005</verification_date>
</DOC>